Susquehanna International Group’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-187,200
| Closed | -$487K | – | 13975 |
|
|
2025
Q4 | $487K | Buy |
187,200
+79,100
| +73% | +$159K | ﹤0.01% | 8849 |
|
|
2025
Q3 | $190K | Buy |
108,100
+10,900
| +11% | +$17.5K | ﹤0.01% | 11047 |
|
|
2025
Q2 | $135K | Buy |
+97,200
| New | +$127K | ﹤0.01% | 11584 |
|
|
2024
Q2 | – | Sell |
-12,500
| Closed | -$58.9K | – | 13054 |
|
|
2024
Q1 | $58.9K | Sell |
12,500
-14,800
| -54% | -$94.8K | ﹤0.01% | 11493 |
|
|
2023
Q4 | $199K | Sell |
27,300
-205,300
| -88% | -$1.15M | ﹤0.01% | 10690 |
|
|
2023
Q3 | $2.81M | Buy |
+232,600
| New | +$2.4M | ﹤0.01% | 4502 |
|
|
2023
Q2 | – | Sell |
-10,000
| Closed | -$98.4K | – | 12975 |
|
|
2023
Q1 | $98.4K | Buy |
+10,000
| New | +$115K | ﹤0.01% | 11312 |
|
|
2022
Q4 | – | Sell |
-50,900
| Closed | -$617K | – | 13501 |
|
|
2022
Q3 | $617K | Buy |
50,900
+2,900
| +6% | +$37.3K | ﹤0.01% | 7912 |
|
|
2022
Q2 | $672K | Buy |
48,000
+37,000
| +336% | +$436K | ﹤0.01% | 7535 |
|
|
2022
Q1 | $157K | Buy |
+11,000
| New | +$163K | ﹤0.01% | 11515 |
|
|
2021
Q4 | – | Sell |
-11,300
| Closed | -$297K | – | 13794 |
|
|
2021
Q3 | $297K | Buy |
11,300
+2,000
| +22% | +$64.6K | ﹤0.01% | 10625 |
|
|
2021
Q2 | $290K | Buy |
+9,300
| New | +$305K | ﹤0.01% | 10829 |
|
Susquehanna International Group's RPTX Position: Q2 2025 in Review
Susquehanna International Group sold out of Repare Therapeutics (RPTX) in Q2 2025, closing a stake of 40,096 shares — an estimated $52.3K sold.
Susquehanna International Group first reported a position in RPTX in Q4 2020 and held it in 9 quarters. The position peaked at $569K in Q3 2023. 50 funds tracked by Wall St. Rank hold RPTX as of Q2 2025.
- Susquehanna International Group reported no remaining Repare Therapeutics position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 40,096 Repare Therapeutics shares in Q2 2025, an estimated $52.3K.
- Susquehanna International Group first reported a position in Repare Therapeutics in Q4 2020 and held it in 9 quarters.
- Susquehanna International Group's Repare Therapeutics position peaked at $569K in Q3 2023.
- 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.